[
    [
        {
            "time": "2018-09-12",
            "original_text": "格隆汇港股聚焦(9.12)︱众安在线前8月原保费收入增近两成 复宏汉霖将于9月25日登陆港交所",
            "features": {
                "keywords": [
                    "众安在线",
                    "复宏汉霖",
                    "港交所",
                    "原保费收入"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "保险",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(9.12)︱众安在线前8月原保费收入增近两成 复宏汉霖将于9月25日登陆港交所",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "从合作办厂到全链条板块合作 外资药企的新“玩法”",
            "features": {
                "keywords": [
                    "外资药企",
                    "全链条合作"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "从合作办厂到全链条板块合作 外资药企的新“玩法”",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复星医药(600196.SH)：复宏汉霖就在研产品HLX10拟授予Kalbe GeneXine在10个国家独家开展商业化 获支付至多6.82亿美元及销售提成",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "HLX10",
                    "商业化合作"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复宏汉霖就在研产品HLX10拟授予Kalbe GeneXine在10个国家独家开展商业化 获支付至多6.82亿美元及销售提成",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复星医药(02196.HK)就研产品HLX10签署许可条款书以加快拓展东南亚市场",
            "features": {
                "keywords": [
                    "复星医药",
                    "HLX10",
                    "东南亚市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)就研产品HLX10签署许可条款书以加快拓展东南亚市场",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复星医药(02196.HK)重组抗PD-1人源化单克隆抗体注射液联合化疗启动III期临床研究",
            "features": {
                "keywords": [
                    "复星医药",
                    "PD-1",
                    "单克隆抗体",
                    "临床研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)重组抗PD-1人源化单克隆抗体注射液联合化疗启动III期临床研究",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复星医药(600196.SH)：HLX10联合化疗用于治疗未接受过治疗的广泛期小细胞肺癌启动III期临床研究",
            "features": {
                "keywords": [
                    "复星医药",
                    "HLX10",
                    "小细胞肺癌",
                    "临床研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：HLX10联合化疗用于治疗未接受过治疗的广泛期小细胞肺癌启动III期临床研究",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复星医药(600196.SH)：复宏汉霖已刊发招股章程 H股发行价每股49.6港元-57.8港元",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "H股发行",
                    "招股章程"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复宏汉霖已刊发招股章程 H股发行价每股49.6港元-57.8港元",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "新商业模式会给未来的药企带来什么？",
            "features": {
                "keywords": [
                    "新商业模式",
                    "药企"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "新商业模式会给未来的药企带来什么？",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "复宏汉霖——复星医药旗下创新药生物医药公司",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "复星医药",
                    "创新药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复宏汉霖——复星医药旗下创新药生物医药公司",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "一致性评价进展分析：齐鲁双赢 苯磺酸氨氯地平片最热",
            "features": {
                "keywords": [
                    "一致性评价",
                    "齐鲁制药",
                    "苯磺酸氨氯地平片"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一致性评价进展分析：齐鲁双赢 苯磺酸氨氯地平片最热",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "茅台们大跌：黄牛靠边，资金作祟",
            "features": {
                "keywords": [
                    "茅台",
                    "大跌",
                    "黄牛",
                    "资金"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "茅台们大跌：黄牛靠边，资金作祟",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "逾30家A股公司计划分拆上市",
            "features": {
                "keywords": [
                    "A股",
                    "分拆上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "逾30家A股公司计划分拆上市",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "早间公告：天业通联、中京电子重组事项近日上会",
            "features": {
                "keywords": [
                    "天业通联",
                    "中京电子",
                    "重组"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "早间公告：天业通联、中京电子重组事项近日上会",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]